Logos Capital
Overview
Logos Capital is a venture capital firm founded in 2019 that is dedicated to advancing healthcare through disciplined, data-driven investments in biotechnology. The firm, led by founder Dr. Arsani William, combines scientific and financial expertise to identify and fund life-changing therapeutics that generate superior long-term returns for investors. It utilizes a proprietary data science platform, Logos Analytics, to enhance decision-making by predicting clinical trial outcomes. The firm invests in both private and public companies.
Portfolio Companies
67
Website
logoscapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ELVN-ELVN | Jan 2022 | Series B | Co-investor |
| Neumora | Oct 2021 | Series A | Co-investor |
| LianBio | Oct 2020 | Series A | Co-investor |
| Verve | Jan 2021 | Series B | Co-investor |
| Jade Biosciences, Inc. | Apr 2025 | M&A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Logos Capital based?
Logos Capital is headquartered in San Francisco, California, United States.
When was Logos Capital founded?
Founding year information for Logos Capital is not publicly available.
How many portfolio companies does Logos Capital have?
Logos Capital has 67 portfolio companies in Caplight's dataset.
What are some companies in Logos Capital's portfolio?
Portfolio companies visible on Caplight include ELVN-ELVN, Neumora, LianBio, Verve, Jade Biosciences, Inc..
What was Logos Capital's most recent investment shown here?
Logos Capital's most recent investment in this portfolio sample was in Jade Biosciences, Inc. in 2025.
What sectors does Logos Capital focus on?
Logos Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Logos Capital focus on?
Logos Capital typically invests at the Mid stage.
What is Logos Capital's AUM?
Logos Capital's assets under management are estimated between $903.8M and $1.5B.